Addition of CYTOMEL therapy in clients with diabetes mellitus may well worsen glycemic Handle and end in elevated antidiabetic agent or insulin needs. Carefully keep an eye on glycemic control, particularly when CYTOMEL is began, adjusted, or discontinued [see WARNINGS AND Safety measures]. On account of inconsistencies involving the drug http://www.t3tiromel.com